LAMA+LABA complex, ‘Vahelva Respimat’ launches with insurance benefit on April

Published: 2016-03-10 15:17:50

Updated: 2016-03-10 15:17:50

A new LAMA+LABA complex drug, Vahelva Respimat(generic name: tiotropium+olodaterol) is expected to be launched on April 1.

On the 8^th, Boehringer Ingelheim(CEO Gi-hwan Park) introduced Vahelva Respimat and Spiriva Respimat(generic name: tiotropium) and announced plans to share the two treatments’ clinical efficacy and recent treatment information.

Vahelva, the company’s first new LAMA+LABA ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.